Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-13 | Amended | $4,434,630 | $2,505,238 | Equity Only | 06b | SEC link |
| 2026-03-13 | New | $420,693 | $420,693 | Equity Only | 06b | SEC link |
| 2022-05-11 | Amended | $1,929,392 | $1,929,392 | Equity Only | 06b | SEC link |
| 2020-05-26 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2019-12-30 | Amended | $550,000 | $250,000 | Equity Only | 06b | SEC link |
| 2019-07-19 | Amended | $300,000 | $250,000 | Equity Only | 06b | SEC link |
| 2018-08-02 | New | $50,000 | $50,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Bill Ashley | Director, Promoter |
| Christopher Brandt | Director |
| Michael Coe | Director, Executive |
| Bradley Holliday | Director |
| Scott Nagley | Director |
| Rajeet Pannu | Director, Promoter |
| Lynn Rundle | Director |
| David Schaefer | Director, Executive, Promoter |
| Steve Schram | Director, Promoter |
| Douglas` Shane | Director, Promoter |
| Douglas Shane | Director, Promoter |
| Nathan Singh | Director |
| Xiomara Sinisterra Hunter | Director |
| Matthew Tomich | Director, Promoter |
| Randall Tosh | Director, Executive |